ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

ClinicalTrials.gov ID: NCT06814145

Public ClinicalTrials.gov record NCT06814145. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 10:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)

Study identification

NCT ID
NCT06814145
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
130 participants

Conditions and interventions

Interventions

  • Sotatercept Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 15, 2025
Primary completion
Mar 29, 2029
Completion
Mar 29, 2029
Last update posted
Apr 5, 2026

2025 – 2029

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Pulmonary Associates, PA ( Site 1008) Phoenix Arizona 85032 Active, not recruiting
Jeffrey S. Sager, MD Medical Corporation ( Site 1060) Santa Barbara California 93105 Active, not recruiting
Stanford University Medical Center ( Site 1024) Stanford California 94305 Active, not recruiting
South Denver Cardiology Associates ( Site 1091) Littleton Colorado 80120 Active, not recruiting
Yale New Haven Hospital ( Site 1093) New Haven Connecticut 06520 Active, not recruiting
AdventHealth Orlando ( Site 1058) Orlando Florida 32803 Active, not recruiting
The Emory Clinic ( Site 1030) Atlanta Georgia 30322 Recruiting
Norton Pulmonary Specialists ( Site 1066) Louisville Kentucky 40202 Active, not recruiting
University Of Nebraska Medical Center ( Site 1053) Omaha Nebraska 68198 Active, not recruiting
Weill Cornell Medical Center ( Site 1046) New York New York 10065 Active, not recruiting
Duke University Medical Center ( Site 1026) Durham North Carolina 27710-4000 Recruiting
The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital ( Site 1001) Cincinnati Ohio 45219 Active, not recruiting
The Cleveland Clinic Foundation. ( Site 1065) Cleveland Ohio 44195 Active, not recruiting
The Ohio State University Wexner Medical Center ( Site 1032) Columbus Ohio 43210 Active, not recruiting
Allegheny General Hospital ( Site 1088) Pittsburgh Pennsylvania 15212-4737 Active, not recruiting
Lankenau Medical Center ( Site 1089) Wynnewood Pennsylvania 19096 Active, not recruiting
Rhode Island Hospital ( Site 1039) Providence Rhode Island 02903 Active, not recruiting
Medical University of South Carolina ( Site 1003) Charleston South Carolina 29425 Active, not recruiting
Statcare Pulmonary Consultants ( Site 1031) Knoxville Tennessee 37919 Active, not recruiting
Intermountain Medical Center ( Site 1079) Murray Utah 84107 Active, not recruiting
Inova Fairfax Medical Campus ( Site 1078) Falls Church Virginia 22042 Active, not recruiting
Pulmonary Associates of Richmond - West Broad Street ( Site 1069) Richmond Virginia 23230 Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06814145, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06814145 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →